Literature DB >> 18547596

Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function.

Carla Ferrada1, Sergi Ferré, Vicent Casadó, Antonio Cortés, Zuzana Justinova, Chanel Barnes, Enric I Canela, Steven R Goldberg, Rob Leurs, Carme Lluis, Rafael Franco.   

Abstract

The striatum contains a high density of histamine H(3) receptors, but their role in striatal function is poorly understood. Previous studies have demonstrated antagonistic interactions between striatal H(3) and dopamine D(1) receptors at the biochemical level, while contradictory results have been reported about interactions between striatal H(3) and dopamine D(2) receptors. In this study, by using reserpinized mice, we demonstrate the existence of behaviorally significant antagonistic postsynaptic interactions between H(3) and D(1) and also between H(3) and dopamine D(2) receptors. The selective H(3) receptor agonist imetit inhibited, while the H(3) receptor antagonist thioperamide potentiated locomotor activation induced by either the D(1) receptor agonist SKF 38393 or the D(2) receptor agonist quinpirole. High scores of locomotor activity were obtained with H(3) receptor blockade plus D(1) and D(2) receptor co-activation, i.e., when thioperamide was co-administered with both SKF 38393 and quinpirole. Radioligand binding experiments in striatal membrane preparations showed the existence of a strong and selective H(3)-D(2) receptor interaction at the membrane level. In agonist/antagonist competition experiments, stimulation of H(3) receptors with several H(3) receptor agonists significantly decreased the affinity of D(2) receptors for the agonist. This kind of intramembrane receptor-receptor interactions are a common biochemical property of receptor heteromers. In fact, by using Bioluminescence Resonance Energy Transfer techniques in co-transfected HEK-293 cells, H(3) (but not H(4)) receptors were found to form heteromers with D(2) receptors. This study demonstrates an important role of postsynaptic H(3) receptors in the modulation of dopaminergic transmission by means of a negative modulation of D(2) receptor function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18547596      PMCID: PMC2435196          DOI: 10.1016/j.neuropharm.2008.05.008

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  43 in total

1.  High constitutive activity of native H3 receptors regulates histamine neurons in brain.

Authors:  S Morisset; A Rouleau; X Ligneau; F Gbahou; J Tardivel-Lacombe; H Stark; W Schunack; C R Ganellin; J C Schwartz; J M Arrang
Journal:  Nature       Date:  2000-12-14       Impact factor: 49.962

2.  Regulation of heptaspanning-membrane-receptor function by dimerization and clustering.

Authors:  Rafael Franco; Meritxell Canals; Daniel Marcellino; Sergi Ferré; Luigi Agnati; Josefa Mallol; Vicent Casadó; Francisco Ciruela; Kjell Fuxe; Carmen Lluis; Enric I Canela
Journal:  Trends Biochem Sci       Date:  2003-05       Impact factor: 13.807

Review 3.  Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons.

Authors:  Luigi F Agnati; Sergi Ferré; Carme Lluis; Rafael Franco; Kjell Fuxe
Journal:  Pharmacol Rev       Date:  2003-07-17       Impact factor: 25.468

Review 4.  Histaminergic transmission in the mammalian brain.

Authors:  J C Schwartz; J M Arrang; M Garbarg; H Pollard; M Ruat
Journal:  Physiol Rev       Date:  1991-01       Impact factor: 37.312

5.  Heterogeneous distributions of histamine H3, dopamine D1 and D2 receptors in rat brain.

Authors:  J H Ryu; K Yanai; R Iwata; T Ido; T Watanabe
Journal:  Neuroreport       Date:  1994-01-31       Impact factor: 1.837

6.  Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes.

Authors:  T Oda; N Morikawa; Y Saito; Y Masuho; S Matsumoto
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

Review 7.  The histamine H4 receptor as a new therapeutic target for inflammation.

Authors:  Iwan J P de Esch; Robin L Thurmond; Aldo Jongejan; Rob Leurs
Journal:  Trends Pharmacol Sci       Date:  2005-09       Impact factor: 14.819

8.  Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors.

Authors:  E Schlicker; K Fink; M Detzner; M Göthert
Journal:  J Neural Transm Gen Sect       Date:  1993

9.  Histamine h3 receptor antagonists potentiate methamphetamine self-administration and methamphetamine-induced accumbal dopamine release.

Authors:  Patrik Munzar; Gianluigi Tanda; Zuzana Justinova; Steven R Goldberg
Journal:  Neuropsychopharmacology       Date:  2004-04       Impact factor: 7.853

Review 10.  International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers.

Authors:  Jean-Philippe Pin; Richard Neubig; Michel Bouvier; Lakshmi Devi; Marta Filizola; Jonathan A Javitch; Martin J Lohse; Graeme Milligan; Krzysztof Palczewski; Marc Parmentier; Michael Spedding
Journal:  Pharmacol Rev       Date:  2007-03       Impact factor: 25.468

View more
  61 in total

1.  Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism.

Authors:  Thomas V Fernandez; Stephan J Sanders; Ilana R Yurkiewicz; A Gulhan Ercan-Sencicek; Young-Shin Kim; Daniel O Fishman; Melanie J Raubeson; Youeun Song; Katsuhito Yasuno; Winson S C Ho; Kaya Bilguvar; Joseph Glessner; Su Hee Chu; James F Leckman; Robert A King; Donald L Gilbert; Gary A Heiman; Jay A Tischfield; Pieter J Hoekstra; Bernie Devlin; Hakon Hakonarson; Shrikant M Mane; Murat Günel; Matthew W State
Journal:  Biol Psychiatry       Date:  2011-12-14       Impact factor: 13.382

2.  Ciproxifan, an H3 receptor antagonist, alleviates hyperactivity and cognitive deficits in the APP Tg2576 mouse model of Alzheimer's disease.

Authors:  Mark E Bardgett; Natasha N Davis; Patrick J Schultheis; Molly S Griffith
Journal:  Neurobiol Learn Mem       Date:  2010-11-10       Impact factor: 2.877

Review 3.  Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance.

Authors:  Melissa L Perreault; Ahmed Hasbi; Brian F O'Dowd; Susan R George
Journal:  Neuropsychopharmacology       Date:  2013-06-18       Impact factor: 7.853

4.  The H3 antagonist, ciproxifan, alleviates the memory impairment but enhances the motor effects of MK-801 (dizocilpine) in rats.

Authors:  Mark E Bardgett; Megan Points; Jennifer Kleier; Meredith Blankenship; Molly S Griffith
Journal:  Neuropharmacology       Date:  2010-07-16       Impact factor: 5.250

5.  Striatal Signaling Regulated by the H3R Histamine Receptor in a Mouse Model of tic Pathophysiology.

Authors:  Maximiliano Rapanelli; Luciana Frick; Kantiya Jindachomthong; Jian Xu; Hiroshi Ohtsu; Angus C Nairn; Christopher Pittenger
Journal:  Neuroscience       Date:  2018-09-29       Impact factor: 3.590

6.  Effects of histamine H(3) receptor activation on the behavioral-stimulant effects of methamphetamine and cocaine in mice and squirrel monkeys.

Authors:  Matthew L Banks; Daniel F Manvich; Rayna M Bauzo; Leonard L Howell
Journal:  Pharmacology       Date:  2009-01-15       Impact factor: 2.547

7.  Histamine is required for H₃ receptor-mediated alcohol reward inhibition, but not for alcohol consumption or stimulation.

Authors:  J Vanhanen; S Nuutinen; M Lintunen; T Mäki; J Rämö; K Karlstedt; P Panula
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

Review 8.  Genetic susceptibility and neurotransmitters in Tourette syndrome.

Authors:  Peristera Paschou; Thomas V Fernandez; Frank Sharp; Gary A Heiman; Pieter J Hoekstra
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

9.  Functional characterization of G-protein-coupled receptors: a bioinformatics approach.

Authors:  L Tovo-Rodrigues; A Roux; M H Hutz; L A Rohde; A S Woods
Journal:  Neuroscience       Date:  2014-07-02       Impact factor: 3.590

10.  Pharmacologic attenuation of pelvic pain in a murine model of interstitial cystitis.

Authors:  Charles N Rudick; Anthony J Schaeffer; David J Klumpp
Journal:  BMC Urol       Date:  2009-11-12       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.